China Regulatory and Market Access Pharmaceutical Report (2013)

China Regulatory and Market Access Pharmaceutical Report (2013)


April 1, 2013
SKU: PACB5018077
License type:
PDF E-mail From Publisher      US $1,200.00
Countries covered: China

China’s pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. This brand new report covers the best way to register your drug there and optimize market access to increase sales in China.

Drug regulations are complicated in China. This report discusses clinical trials, required drug documentation for approval, GCP, GMP, etc.

Once your drug is approved, what needs to be done to sell it in China? This report also covers issues like drug pricing, reimbursement, provincial bidding, hospital tenders, etc.

This report includes 17 appendices. They include application forms for pharmaceutical products, a list of Chinese CROs, the essential and national reimbursement drug lists, etc.

Pages: 282 (Including 98 pages of the basic report and 184 pages in the Appendix)



More Clinical Trial reports by Pacific Bridge Medical

India Pharmaceutical Regulatory Report 2012  by Pacific Bridge Medical
The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, ...
Orphan Drugs in Asia 2012 by Pacific Bridge Medical
Following the example of the US FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislations, such as Singapore's Orphan ...
See all reports like this >>

More China Clinical Trial reports

Marine Freight in China by MarketLine
Marine Freight in ChinaIntroductionMarine Freight in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). ...
China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Impo by Access China Management Consulting Ltd.
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese ...
China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medi by Access China Management Consulting Ltd.
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition ...
The 2013-2018 Outlook for E-Clinical Trial Technologies in Greater China by Icon Group International, Inc.
The 2013-2018 Outlook for E-Clinical Trial Technologies in Greater ChinaThis econometric study covers the latent demand outlook for e-clinical trial technologies across the regions of ...
See all reports like this >>

More China reports

Eyewear in Hong Kong, China by Euromonitor International
Eyewear in Hong Kong, ChinaThe growth rate has been slowing down since 2011 in the eyewear market. The economy in Hong Kong and China saw ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>